The HRA is currently reviewing all its website material to ensure greater consistency in the use of language in conveying standards that should be followed (ethical obligations or best practice) or must be followed (legal requirements). Readers should be aware that the HRA holds both in high regard. For further information please see the HRA website conditions which can be found here.

Dr Richard Tiner

Published on 7 March 2017

It is with great sadness that we hear of the news of the death of a close friend of the Health Research Authority, Dr Richard Tiner.

A former general practitioner in the South West of England for many years, Richard …

Confidentiality Advisory Group Patient Involvement Workshop

Published on 31 January 2017

Registration for this event has now closed due to a large number of expressions of interest. Those who obtained a place will be contacted on Monday 13th  February.

London Marriot County Hall, 22 February 2017, 9am-1pm

The Health Research …

HRA publishes new proportionate consent guidance

Published on 31 January 2017

The HRA is encouraging researchers to take a more proportionate approach to the process of seeking consent for participation in research.

Researchers have an ethical and legal obligation to make sure that people volunteering for research projects have the information …

Have your say on the HRA website

Published on 9 January 2017

We’re about to begin work to improve the HRA website – we want to make it easier to access the information you need. We’d love to hear your thoughts on what you like and don’t like about our current site, …

HRA Christmas opening hours

Published on 12 December 2016

Please note that the HRA will be offering a reduced service over the Christmas and New Year period. Details of all service opening hours are below:

  • Central Booking Service (0207 104 8000) – Closes on Thursday 22 December at 1pm,

New HRA Approval leaflet

Published on 10 November 2016

In response to requests, the Health Research Authority (HRA) has published a new brief leaflet setting out high level information about the HRA Approval process.

It provides an overview, highlighting our aim to simplify and streamline the approval process.

The …

HRA response to the European Medicines Agency Concept paper on the revision of the Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products

Published on 3 October 2016

The European Medicines Agency (EMA), in cooperation with the European Commission and the Member States of the European Union (EU), has recently consulted on a concept paper on the revision of the ‘Guideline on strategies to identify and mitigate risks …

Page 1 of 1612345